Evidence map›Paper›PMID 31619398›Full record

ArticleBMJ case reports2019

Iron III isomaltose induced hypersensitivity reaction.

Mahreen Muzammil, Kashif Aziz, Muhammad Ehteram Ul Haq, Nosheen Nasir

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mahreen MuzammilDepartment of Pharmacy Services, Aga Khan University, Karachi, Pakistan mahreen.muzammil@aku.edu.
Kashif AzizDepartment of Medicine, Aga Khan University, Karachi, Pakistan.
Muhammad Ehteram Ul HaqPost Graduate Medical Education, Aga Khan University, Karachi, Pakistan.
Nosheen NasirDepartment of Medicine, Aga Khan University, Karachi, Pakistan.
Aga Khan University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron isomaltose is considered as safe form of iron with no test dose recommended. Here, we are describing the case of a patient who experienced allergic reaction with this formulation of iron. A 35-year-old South Asian woman experienced allergic reaction, she had mild wheeze on examination of chest. She was given intranasal oxygen at 2 L/min. She was given intravenous acetaminophen 1 g for pain relief, 45.4 mg intravenous chlorphenaramine and intravenous 100 mg hydrocortisone. Within half an hour, all her symptoms improved and her hypoxia resolved. Her chest wheezing also disappeared. Iron isomaltose, although relatively safe, can cause allergic reaction. Intravenous iron can cause allergic reaction therefore it should be administered at the facility where trained staff is present so that necessary treatment can be given in case of hypersensitivity reaction.

Indexed as

AcetaminophenAdultAnalgesics, Non-NarcoticAnti-Inflammatory AgentsDrug HypersensitivityDyspneaFemaleHumansHydrocortisoneIronIsomaltoseOxygen Inhalation TherapyAcetaminophenAnalgesics, Non-NarcoticAnti-Inflammatory AgentsHydrocortisoneIronIsomaltosedrug interactionsunwanted effects / adverse reactions

Identifiers

PMID31619398
PMCPMC6803082
OpenAlexW2980756412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.